Assignee
INDAPTA THERAPEUTICS INC
US·3 granted patents·6 pending applications·0 citations·filing 2018–2025
Top patents by PatentIndex Score
9 records- 0176US12564739B2Engineered natural killer (NK) cells and compositions and methods thereofINDAPTA THERAPEUTICS INC·Filed 2024·Granted Mar 3, 2026·0 cites·23 claims
- 0262US11920156B2Engineered natural killer (NK) cells and compositions and methods thereofINDAPTA THERAPEUTICS INC·Filed 2018·Granted Mar 5, 2024·0 cites·18 claims
- 0358US2026043006A1Methods for expansion of natural killer (nk) cell subset and related compositions and methodsINDAPTA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0456US2025375524A1Combination of engineered natural killer (nk) cells and antibody therapy and related methodsINDAPTA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0555US12410402B2Methods for expansion of natural killer (NK) cell subset and related compositions and methodsINDAPTA THERAPEUTICS INC·Filed 2019·Granted Sep 9, 2025·0 cites·40 claims
- 0649US2024316102A1Engineered natural killer (nk) cells and related methodsINDAPTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0749US2021187025A1Subsets of human natural killer cells with enhanced antibody-directed immune responsesINDAPTA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0848US2024197783A1Methods of treatment and dosing of natural killer cell compositionsINDAPTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0946US2023190801A1Natural killer (nk) cell compositions and methods for generating sameINDAPTA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when INDAPTA THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →